STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The company is headquartered in Monrovia California, California and currently employs 957 full-time employees. The firm markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The firm's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). The company also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. The company makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.
Quelle est la performance du prix de l'action STAA ?
Le prix actuel de STAA est de $26.28, il a diminué de 9.31% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de STAAR Surgical Co ?
STAAR Surgical Co appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de STAAR Surgical Co ?
La capitalisation boursière actuelle de STAAR Surgical Co est de $1.3B
Est-ce que STAAR Surgical Co est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 11 analystes ont établi des notations d'analystes pour STAAR Surgical Co, y compris 0 achat fort, 0 achat, 11 maintien, 2 vente et 0 vente forte